Amyotrophic Lateral Sclerosis and Riluzole: Understanding Progression and Treatment
Riluzole is the first FDA-approved drug for ALS, modestly extending survival by 2-3 months. It works by reducing glutamate toxicity, slowing motor neuron death. Despite side effects and limited efficacy, it remains the cornerstone of ALS treatment worldwide.
